Colorectal Cancer - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Colorectal Cancer

Description:

Second leading cause of cancer death in US - approx 148,000 cases/yr and 58,000 deaths ... Colonoscope inserted to the descending colon ... – PowerPoint PPT presentation

Number of Views:58
Avg rating:3.0/5.0
Slides: 36
Provided by: lifebrid
Category:

less

Transcript and Presenter's Notes

Title: Colorectal Cancer


1
Colorectal Cancer
  • Niraj Jani, MD
  • Div of Gastroenterology
  • Sinai Hospital

2
Epidemiology
  • Second leading cause of cancer death in US -
    approx 148,000 cases/yr and 58,000 deaths
  • Equal lifetime risk between men and women
  • 93 of cases dx over age 50. Five-year survival
    of 60
  • Treatment costs over 6.5 billion per year
  • Among malignancies, second only to breast cancer
    at 6.6 billion per year

3
Epidemiology
  • Industrialized nations have the greatest risk

Geographic distribution of sporadic colon cancer
4
Pathogenesis
  • Adenoma to Carcinoma sequence

5
Pathogenesis
  • Adenomatous polyps and adenocarcinoma are
    epithelial tumors of the large intestine
  • Risk factors for polyps/adenomas to develop into
    cancer
  • Patient age (greatly increased after 50 yo, with
    prevalence doubling until age 80)
  • Adenomas greater than 1 cm
  • Extensive villous patterns

6
Pathogenesis
Polyp/Cancer locations
7
CRC Risk Factors
  • Age CRC incidence increases rapidly after 50
    years of age
  • Adenomatous Polyps
  • 30 at 50 years, 40-50 at 60 years, and up to
    65 at 70 years
  • Most importantly, the risk of HGD in a polyp is
    80 higher in an older person than younger person

8
CRC Risk Factors
  • Diet Greatest association is between high fat
    diet/red meat and CRC
  • High cholesterol, obesity linked to CRC
  • A prospective study of more than 760,000 people
    showed diets rich in vegetables and high fiber
    grains demonstrated significant protection
    against fatal CRC

9
Diet and Colon Cancer
  • Protective factors
  • Fiber
  • decreases fecal transit time by increasing stool
    bulk
  • Dilutes the concentration of other colonic
    constituents which minimizes interactions btwn
    carcinogens and colon epithelium
  • Reduces colonic pH and generates short chain
    fatty acids

10
CRC Risk Factors
  • Other risk factors
  • Hx of Ulcerative Colitis
  • Strep Bovis infection
  • Ureterosigmoidostomy
  • Dermatomyositis
  • Pelvic Irradiation
  • Smoking/ETOH consumption
  • Obesity

11
CRC Protective Factors
  • Other protective factors
  • Exercise
  • NSAIDs/ASA
  • Folate
  • High calcium intake
  • Hormonal therapy
  • Selenium

12
CRC Risk Factors
  • Genetics

13
CRC Risk Factors
  • Familial clustering present in 15 of all cases
    of CRC
  • Increased risk 1.5-2.0 fold
  • Individuals with hx of adenomas are at three to
    sixfold increased risk of metachronous neoplasms

14
Genetic Sydromes
  • Familial adenomatous polyposis (FAP) an
    inherited condition caused by a germline mutation
    on chromosome 5 (APC gene)
  • Leads to hundreds to thousands of polyps
    throughout the GI tract
  • Other findings include
  • - duodenal adenomas
  • - fundic gland hyperplasia
  • - mandibular osteomas
  • - supernumerary teeth

15
FAP
16
Genetic Sydromes
  • Attenuated FAP (lt100 adenomas) and later onset
    of CRC
  • Turcots Syndrome familial predisposition for
    colonic polyposis and CNS tumors
  • Gardners Syndrome variant of FAP
  • Osteomas of the skull and long bones
  • (CHRPE) Congenital Hypertrophy of the Retinal
    Pigmented Epithelium

17
Genetic Sydromes
  • Hereditary nonpolyposis colorectal cancer (HNPCC)
    syndrome also called Lynch syndrome
    characterized by proximal cancer in 3rd and 4th
    decade of life
  • Also associated with extracolonic cancers-
    (uterus, ovaries, stomach, small bowel and bile
    duct)
  • Mutations in DNA mismatch repair genes (MLH1,
    MSH2)

18
HNPCC
  • Amsterdam Criteria for Dx of HNPCC
  • gt 3 relatives with HNPCC related cancers
  • 2. gt 1 case is a first-degree relative of
    2 other
  • cases
  • 3. gt 2 successive generations affected
  • 4. gt 1 case diagnosed before age 50 years

19
Genetic Sydromes
  • Other Genetic Diseases linked to CRC
  • Muir-Torre Syndrome
  • Peutz-Jeghers Syndrome
  • Tuberous Sclerosis
  • Juvenile Polyposis Sydrome
  • Cowden disease
  • Cronkhite-Canada Syndrome

20
Screening
  • Annual Fecal Occult Blood Test (FOBT)
  • Flexible Sigmoidoscopy every 5 years
  • Annual FOBT Flexible Sigmoidoscopy every 5
    years
  • Colonoscopy every 10 years
  • Double Contrast Barium Enema (DCBE) every 5 years

21
FOBT
  • Uses the peroxidase activity of hemoglobin to
    cause a change in a reagent
  • Consume diets high in fiber, restrict red meat
    consumption, vitamin C, and NSAID drugs for
    several days prior to testing
  • The sensitivity of fecal occult blood testing
    ranges from 3092 with a specificity of 98

22
Barium Enema
-- The complication rate with the procedure is
very low the rate of perforation is 1 in
25,000 examinations -- The sensitivity of
double contrast barium enema ranges from 3990
23
Flexible Sigmoidoscopy
  • Colonoscope inserted to the descending colon
  • 60 of all neoplasms are within this
    distribution- therefore, flex sigmoidoscopy along
    with FOBT provides an effective screening tool
  • Minimal prep and no sedation required office
    procedure performed by internists, fam med docs,
    NPs
  • Perforation risk 1-2/10,000

24
Colonoscopy
  • Gold standard for CRC screening
  • Risk of complications 0.10.3 risk of
    hemorrhage and perforation
  • Allows for mucosal biopsy, polypectomy,
    tattooing, accurate localization and
    flushing/suctioning
  • Sensitivity of colonoscopy for the detection of
    polyps greater than or equal to 1 cm and tumors
    is greater than 95

25
Colonoscopy
26
Chemoprevention
  • COX-II inhibitors
  • Estrogens
  • Ursodeoxycholic Acid

27
Adenocarcinoma
TNM and Dukes Staging for CRC
28
Treatment
  • Primary treatment for early colon cancer is
    surgery. For rectal cancer, total mesorectal
    excision
  • In tumors that are gt T3 or gt N1, preoperative
    chemo is recommended
  • Radiation is useful in rectal cancer, not colon
    cancer

29
CRC Treatment
  • Common chemotherapeutic regimen includes
    5-fluorouracil, leucovorin, oxaliplatin (FOLFOX)
  • Other agents include bevacizumab,
    cetuximab,irinotecan, capecitabine

30
Question 1
  • A 32 yo male presents for annual health
    maintenance visit. His mother was dx with colon
    cancer at age 55. Patient should undergo
    screening at what age?
  • A. Now
  • 40 yo
  • 45 yo
  • 50 yo

31
Question 1
  • Pt has a twofold increase in CRC compared to age
    matched controls due to first degree relative
    with cancer
  • Guideline- screen ten years before first-degree
    relative or at age 40 depending on which comes
    first

32
Question 2
  • Three months ago, a 62 yo BM underwent a flex sig
    and was found to have an obstructing mass. He
    underwent a sigmoid resection which was
    considered curative. Did not receive post-op
    chemo/radiation. Which is the most appropriate
    CRC surveillance procedure for this pt?
  • A. Colonoscopy Now
  • B. Colonoscopy In 1 year
  • C. Colonoscopy In 3 years
  • D. CT Abdomen now
  • E. CT Abdomen in 3 years

33
Question 2
  • Synchronous cancers occur in 3-5 of pts found to
    have CRC
  • Pt never had colonoscopy previously
  • Once resection performed- repeat colon in 1 year
    then 3 year intervals
  • Abdominal CT yearly for 3 years

34
Question 3
  • The test of choice for screening 1rst degree
    relatives of pts with FAP is
  • Colonoscopy starting at age 12 every 5 years
  • Genetic testing at age 10 to 12 yo
  • Sigmoidoscopy starting at age 12 every year
  • Sigmoidoscopy starting at age 20 every year
  • No screening

35
Question 3
  • Genetic testing for a mutation in the APC gene if
    the first screening test.
  • If genetic testing is not available, then
    sigmoidoscopy starting at age 12
Write a Comment
User Comments (0)
About PowerShow.com